Teicoplanin aglycone is a glycopeptide antibiotic core structure employed in research to combat Gram-positive bacterial infections, including those from MRSA and Enterococcus faecalis. It is a key tool for in vitro and in vivo studies investigating antibiotic mechanisms, resistance, and the development of novel antibacterial agents.